FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

386979007: Cabergoline (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461157016 Cabergoline (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481093014 Cabergoline en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1461157016 Cabergoline (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1461157016 Cabergoline (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481093014 Cabergoline en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1481093014 Cabergoline en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
59001000195116 cabergolina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
74171000195113 Cabergolin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
192631000077110 cabergoline fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
192631000077110 cabergoline fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
59001000195116 cabergolina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
74171000195113 Cabergolin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabergoline Is a Dopamine agent false Inferred relationship Existential restriction modifier (core metadata concept)
Cabergoline Is a classe d'allergènes false Inferred relationship Existential restriction modifier (core metadata concept)
Cabergoline Is a allergène médicamenteux false Inferred relationship Existential restriction modifier (core metadata concept)
Cabergoline Is a Antiparkinsonian agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Cabergoline Is a Dopamine receptor agonist true Inferred relationship Existential restriction modifier (core metadata concept)
Cabergoline Is a Ergoline derivative (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Cabergoline Has disposition Dopamine receptor agonist true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Cabergoline-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Cabergoline adverse reaction Causative agent (attribute) True Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Allergy to cabergoline Causative agent (attribute) False Cabergoline Inferred relationship Existential restriction modifier (core metadata concept)
Cabergoline [parkinsons] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline Inferred relationship Existential restriction modifier (core metadata concept)
Cabergoline 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline Inferred relationship Existential restriction modifier (core metadata concept)
Cabergoline 2mg tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline Inferred relationship Existential restriction modifier (core metadata concept)
Cabergoline 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline Inferred relationship Existential restriction modifier (core metadata concept)
Cabergoline 500micrograms tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline Inferred relationship Existential restriction modifier (core metadata concept)
Cabergoline 0.5mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline Inferred relationship Existential restriction modifier (core metadata concept)
Allergy to cabergoline Causative agent (attribute) True Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Cabergoline 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Cabergoline 1 mg oral tablet Has basis of strength substance (attribute) True Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Cabergoline 2mg tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Cabergoline 2mg tablet (substance) Has basis of strength substance (attribute) True Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Cabergoline 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Cabergoline 4 mg oral tablet Has basis of strength substance (attribute) True Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Cabergoline 500micrograms tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Cabergoline 500micrograms tablet (substance) Has basis of strength substance (attribute) True Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Cabergoline 500micrograms tablet (substance) Has precise active ingredient True Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Cabergoline 1 mg oral tablet Has precise active ingredient True Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Cabergoline 2mg tablet (substance) Has precise active ingredient True Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Cabergoline 4 mg oral tablet Has precise active ingredient True Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing cabergoline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only cabergoline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only cabergoline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cabergoline Inferred relationship Existential restriction modifier (core metadata concept) 1

Reference Sets

Description inactivation indicator reference set

GB English

Back to Start